4//SEC Filing
GRAF FINCKENSTEIN FRIEDRICH 4
Accession 0001104659-25-021055
CIK 0001425205other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 8:30 PM ET
Size
12.0 KB
Accession
0001104659-25-021055
Insider Transaction Report
Form 4
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-03-03+62,497→ 126,383 total - Tax Payment
Common Stock
2025-03-03$4.04/sh−33,470$135,219→ 92,913 total - Exercise/Conversion
Restricted Stock Units
2025-03-03−3,907→ 15,626 total→ Common stock (3,907 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-03−58,590→ 70,317 total→ Common stock (58,590 underlying)
Footnotes (7)
- [F1]Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- [F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- [F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The remaining RSUs will vest in equal quarterly installments.
- [F6]Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
- [F7]Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.
Documents
Issuer
IOVANCE BIOTHERAPEUTICS, INC.
CIK 0001425205
Entity typeother
Related Parties
1- filerCIK 0001782981
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 8:30 PM ET
- Size
- 12.0 KB